Category Archives: The Charlton Centre

Publicly funded shingles vaccination has been available for many years for adults aged 65-70. Initially, the vaccine provided was Zostavax, which was a live vaccine given as a single dose. Protection decreased with time and by 8 years, very little … Continue reading →

Happy New Year to our Charlton Family! We enter 2023 with much excitement as treatments for autoimmune diseases continue to expand making our ‘tool chest” bigger. Therapies marketed for psoriasis and psoriatic arthritis are being approved for inflammatory bowel diseases, … Continue reading →

As we near the end of 2022, we thought we would share some of our most popular blog posts of the past year with you. We’ve talked about a huge number of subjects this year, but these ones were your … Continue reading →

According to Health Canada’s guidance on fall prevention, falls are the leading cause of injury among older Canadians.  In fact, 20-30% of seniors experience one or more falls each year.  As winter is upon us, so comes the ice and … Continue reading →

We have had many calls asking about the timing of vaccines this fall. As clinical pharmacists working at Charlton Health, we are happy to answer any questions regarding vaccines and the timing of medications. There is no need to separate … Continue reading →

Atopic Dermatitis is commonly referred to as eczema. The foundation of the condition is skin barrier dysfunction, whereby allergens and infectious organisms can penetrate below the skin. This results in the release of histamine and other inflammatory chemicals causing redness … Continue reading →

Health Canada has approved Evusheld as a preventative treatment for COVID-19. It is not intended to replace COVID-19 vaccinations, but rather to add another layer of protection in patients who are predicted to have a poor antibody response to the … Continue reading →

At Charlton Health, a center specializing in advanced treatments including biologic therapies, we are often excited when additional treatment options are made available for patients with autoimmune diseases. Recently, Rinvoq© (upadacitinib), an oral treatment option for Rheumatoid Arthritis, Psoriatic Arthritis … Continue reading →

With updated COVID-19 vaccines becoming available as booster doses to offer better protection against variants of the SARS-COV-2 virus, it is important to be aware of who is eligible to receive them.  At Charlton Health, we continue to serve immunocompromised … Continue reading →